nodes	percent_of_prediction	percent_of_DWPC	metapath
Rocuronium—SLCO1A2—Chlorambucil—ovarian cancer	0.882	1	CbGbCtD
Rocuronium—Injection site swelling—Paclitaxel—ovarian cancer	0.01	0.0857	CcSEcCtD
Rocuronium—Respiratory failure—Topotecan—ovarian cancer	0.00402	0.0344	CcSEcCtD
Rocuronium—Electrocardiogram abnormal—Paclitaxel—ovarian cancer	0.00347	0.0297	CcSEcCtD
Rocuronium—Respiratory failure—Vinorelbine—ovarian cancer	0.00344	0.0295	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Topotecan—ovarian cancer	0.00296	0.0254	CcSEcCtD
Rocuronium—Vomiting—Altretamine—ovarian cancer	0.00283	0.0242	CcSEcCtD
Rocuronium—Nausea—Altretamine—ovarian cancer	0.00265	0.0227	CcSEcCtD
Rocuronium—Bronchospasm—Melphalan—ovarian cancer	0.00239	0.0204	CcSEcCtD
Rocuronium—Respiratory failure—Paclitaxel—ovarian cancer	0.00232	0.0198	CcSEcCtD
Rocuronium—Wheezing—Paclitaxel—ovarian cancer	0.00221	0.0189	CcSEcCtD
Rocuronium—Muscular weakness—Vinorelbine—ovarian cancer	0.00216	0.0185	CcSEcCtD
Rocuronium—Bronchospasm—Vinorelbine—ovarian cancer	0.00209	0.0179	CcSEcCtD
Rocuronium—Respiratory failure—Docetaxel—ovarian cancer	0.00196	0.0168	CcSEcCtD
Rocuronium—Paralysis—Epirubicin—ovarian cancer	0.00187	0.016	CcSEcCtD
Rocuronium—Arrhythmia—Melphalan—ovarian cancer	0.00174	0.0149	CcSEcCtD
Rocuronium—Paralysis—Doxorubicin—ovarian cancer	0.00173	0.0148	CcSEcCtD
Rocuronium—Arrhythmia—Vinorelbine—ovarian cancer	0.00152	0.013	CcSEcCtD
Rocuronium—Cardiovascular disorder—Epirubicin—ovarian cancer	0.00148	0.0127	CcSEcCtD
Rocuronium—Muscular weakness—Paclitaxel—ovarian cancer	0.00146	0.0125	CcSEcCtD
Rocuronium—Anaphylactic shock—Topotecan—ovarian cancer	0.00141	0.0121	CcSEcCtD
Rocuronium—Anaphylactic shock—Melphalan—ovarian cancer	0.00138	0.0118	CcSEcCtD
Rocuronium—Vecuronium—ABCB1—ovarian cancer	0.00137	1	CrCbGaD
Rocuronium—Cardiovascular disorder—Doxorubicin—ovarian cancer	0.00137	0.0117	CcSEcCtD
Rocuronium—Tachycardia—Melphalan—ovarian cancer	0.00135	0.0115	CcSEcCtD
Rocuronium—Hiccups—Epirubicin—ovarian cancer	0.0013	0.0111	CcSEcCtD
Rocuronium—Hypotension—Melphalan—ovarian cancer	0.00129	0.011	CcSEcCtD
Rocuronium—Hypertension—Vinorelbine—ovarian cancer	0.00128	0.0109	CcSEcCtD
Rocuronium—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00121	0.0103	CcSEcCtD
Rocuronium—Hiccups—Doxorubicin—ovarian cancer	0.0012	0.0103	CcSEcCtD
Rocuronium—Bronchospasm—Docetaxel—ovarian cancer	0.00119	0.0102	CcSEcCtD
Rocuronium—Tachycardia—Vinorelbine—ovarian cancer	0.00118	0.0101	CcSEcCtD
Rocuronium—Hypersensitivity—Chlorambucil—ovarian cancer	0.00117	0.00999	CcSEcCtD
Rocuronium—Hypotension—Vinorelbine—ovarian cancer	0.00113	0.00964	CcSEcCtD
Rocuronium—Pruritus—Chlorambucil—ovarian cancer	0.00112	0.00959	CcSEcCtD
Rocuronium—Hypersensitivity—Topotecan—ovarian cancer	0.00104	0.00889	CcSEcCtD
Rocuronium—Arrhythmia—Paclitaxel—ovarian cancer	0.00102	0.00873	CcSEcCtD
Rocuronium—Hypersensitivity—Melphalan—ovarian cancer	0.00102	0.0087	CcSEcCtD
Rocuronium—Vomiting—Chlorambucil—ovarian cancer	0.00101	0.00862	CcSEcCtD
Rocuronium—Pruritus—Topotecan—ovarian cancer	0.000997	0.00854	CcSEcCtD
Rocuronium—Pruritus—Melphalan—ovarian cancer	0.000977	0.00836	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.000975	0.00834	CcSEcCtD
Rocuronium—Nausea—Chlorambucil—ovarian cancer	0.000941	0.00805	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.000902	0.00772	CcSEcCtD
Rocuronium—Vomiting—Topotecan—ovarian cancer	0.000896	0.00767	CcSEcCtD
Rocuronium—Rash—Topotecan—ovarian cancer	0.000889	0.00761	CcSEcCtD
Rocuronium—Hypersensitivity—Vinorelbine—ovarian cancer	0.000889	0.0076	CcSEcCtD
Rocuronium—Dermatitis—Topotecan—ovarian cancer	0.000888	0.0076	CcSEcCtD
Rocuronium—Vomiting—Melphalan—ovarian cancer	0.000878	0.00751	CcSEcCtD
Rocuronium—Rash—Melphalan—ovarian cancer	0.00087	0.00745	CcSEcCtD
Rocuronium—Dermatitis—Melphalan—ovarian cancer	0.00087	0.00744	CcSEcCtD
Rocuronium—Arrhythmia—Docetaxel—ovarian cancer	0.000865	0.0074	CcSEcCtD
Rocuronium—Hypertension—Paclitaxel—ovarian cancer	0.000858	0.00734	CcSEcCtD
Rocuronium—Pruritus—Vinorelbine—ovarian cancer	0.000853	0.0073	CcSEcCtD
Rocuronium—Nausea—Topotecan—ovarian cancer	0.000837	0.00717	CcSEcCtD
Rocuronium—Muscular weakness—Epirubicin—ovarian cancer	0.000832	0.00712	CcSEcCtD
Rocuronium—Nausea—Melphalan—ovarian cancer	0.00082	0.00702	CcSEcCtD
Rocuronium—Asthma—Epirubicin—ovarian cancer	0.000816	0.00698	CcSEcCtD
Rocuronium—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000811	0.00694	CcSEcCtD
Rocuronium—Shock—Paclitaxel—ovarian cancer	0.000798	0.00683	CcSEcCtD
Rocuronium—Tachycardia—Paclitaxel—ovarian cancer	0.000792	0.00678	CcSEcCtD
Rocuronium—Muscular weakness—Doxorubicin—ovarian cancer	0.00077	0.00659	CcSEcCtD
Rocuronium—Vomiting—Vinorelbine—ovarian cancer	0.000767	0.00656	CcSEcCtD
Rocuronium—Rash—Vinorelbine—ovarian cancer	0.00076	0.00651	CcSEcCtD
Rocuronium—Dermatitis—Vinorelbine—ovarian cancer	0.00076	0.0065	CcSEcCtD
Rocuronium—Hypotension—Paclitaxel—ovarian cancer	0.000758	0.00649	CcSEcCtD
Rocuronium—Asthma—Doxorubicin—ovarian cancer	0.000755	0.00646	CcSEcCtD
Rocuronium—Hypertension—Docetaxel—ovarian cancer	0.000727	0.00622	CcSEcCtD
Rocuronium—Nausea—Vinorelbine—ovarian cancer	0.000716	0.00613	CcSEcCtD
Rocuronium—Anaphylactic shock—Docetaxel—ovarian cancer	0.000688	0.00588	CcSEcCtD
Rocuronium—Shock—Docetaxel—ovarian cancer	0.000676	0.00579	CcSEcCtD
Rocuronium—Tachycardia—Docetaxel—ovarian cancer	0.000671	0.00574	CcSEcCtD
Rocuronium—Hypotension—Docetaxel—ovarian cancer	0.000642	0.0055	CcSEcCtD
Rocuronium—Hypersensitivity—Paclitaxel—ovarian cancer	0.000598	0.00511	CcSEcCtD
Rocuronium—Arrhythmia—Epirubicin—ovarian cancer	0.000583	0.00499	CcSEcCtD
Rocuronium—Pruritus—Paclitaxel—ovarian cancer	0.000574	0.00491	CcSEcCtD
Rocuronium—Arrhythmia—Doxorubicin—ovarian cancer	0.00054	0.00462	CcSEcCtD
Rocuronium—Vomiting—Paclitaxel—ovarian cancer	0.000516	0.00441	CcSEcCtD
Rocuronium—Rash—Paclitaxel—ovarian cancer	0.000511	0.00438	CcSEcCtD
Rocuronium—Dermatitis—Paclitaxel—ovarian cancer	0.000511	0.00437	CcSEcCtD
Rocuronium—Hypersensitivity—Docetaxel—ovarian cancer	0.000507	0.00434	CcSEcCtD
Rocuronium—Hypertension—Epirubicin—ovarian cancer	0.000491	0.0042	CcSEcCtD
Rocuronium—Pruritus—Docetaxel—ovarian cancer	0.000486	0.00416	CcSEcCtD
Rocuronium—Nausea—Paclitaxel—ovarian cancer	0.000482	0.00412	CcSEcCtD
Rocuronium—Anaphylactic shock—Epirubicin—ovarian cancer	0.000464	0.00397	CcSEcCtD
Rocuronium—Shock—Epirubicin—ovarian cancer	0.000456	0.0039	CcSEcCtD
Rocuronium—Hypertension—Doxorubicin—ovarian cancer	0.000454	0.00388	CcSEcCtD
Rocuronium—Tachycardia—Epirubicin—ovarian cancer	0.000453	0.00387	CcSEcCtD
Rocuronium—Vomiting—Docetaxel—ovarian cancer	0.000437	0.00374	CcSEcCtD
Rocuronium—Rash—Docetaxel—ovarian cancer	0.000434	0.00371	CcSEcCtD
Rocuronium—Hypotension—Epirubicin—ovarian cancer	0.000433	0.00371	CcSEcCtD
Rocuronium—Dermatitis—Docetaxel—ovarian cancer	0.000433	0.00371	CcSEcCtD
Rocuronium—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000429	0.00367	CcSEcCtD
Rocuronium—Shock—Doxorubicin—ovarian cancer	0.000422	0.00361	CcSEcCtD
Rocuronium—Tachycardia—Doxorubicin—ovarian cancer	0.000419	0.00358	CcSEcCtD
Rocuronium—Nausea—Docetaxel—ovarian cancer	0.000408	0.0035	CcSEcCtD
Rocuronium—Hypotension—Doxorubicin—ovarian cancer	0.000401	0.00343	CcSEcCtD
Rocuronium—Hypersensitivity—Epirubicin—ovarian cancer	0.000342	0.00292	CcSEcCtD
Rocuronium—Pruritus—Epirubicin—ovarian cancer	0.000328	0.00281	CcSEcCtD
Rocuronium—Hypersensitivity—Doxorubicin—ovarian cancer	0.000316	0.00271	CcSEcCtD
Rocuronium—Pruritus—Doxorubicin—ovarian cancer	0.000304	0.0026	CcSEcCtD
Rocuronium—Vomiting—Epirubicin—ovarian cancer	0.000295	0.00252	CcSEcCtD
Rocuronium—Rash—Epirubicin—ovarian cancer	0.000292	0.0025	CcSEcCtD
Rocuronium—Dermatitis—Epirubicin—ovarian cancer	0.000292	0.0025	CcSEcCtD
Rocuronium—Nausea—Epirubicin—ovarian cancer	0.000275	0.00236	CcSEcCtD
Rocuronium—Vomiting—Doxorubicin—ovarian cancer	0.000273	0.00233	CcSEcCtD
Rocuronium—Rash—Doxorubicin—ovarian cancer	0.000271	0.00232	CcSEcCtD
Rocuronium—Dermatitis—Doxorubicin—ovarian cancer	0.00027	0.00231	CcSEcCtD
Rocuronium—Nausea—Doxorubicin—ovarian cancer	0.000255	0.00218	CcSEcCtD
